(VIANEWS) – Euroseas Ltd. (ESEA), EOG Resources (EOG), Semler Scientific (SMLR) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Euroseas Ltd. (ESEA)

171.2% sales growth and 12.74% return on equity

Euroseas Ltd.

Euroseas Ltd.’s sales growth this year is expected to be 65.3% and 34.7% for next year.

Year-on-year quarterly revenue growth declined by 9.6%, now sitting on 53.3M for the twelve trailing months.

Volume

Today’s last reported volume for Euroseas Ltd. is 126984 which is 3.2% below its average volume of 131193.

Euroseas Ltd.’s sales growth is a negative 0% for the current quarter and 171.2% for the next. The company’s growth estimates for the present quarter and the next is 14300% and 3600%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.74%.

Volatility

Euroseas Ltd.’s last day, last week, and last month’s current volatility was 1.19%, 4.06%, and 7.55%, respectively.

Euroseas Ltd.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.32% (day), 7.91% (last week), and 9.32% (last month), respectively.

Euroseas Ltd.’s Stock Yearly Top and Bottom Value

Euroseas Ltd.’s stock is valued at $27.11 at 20:22 EST, way under its 52-week high of $39.17 and way higher than its 52-week low of $2.60.

Euroseas Ltd.’s Moving Average

Euroseas Ltd.’s worth is way under its 50-day moving average of $30.53 and way above its 200-day moving average of $21.32.

2. EOG Resources (EOG)

58.9% sales growth and 9.11% return on equity

EOG Resources, Inc., together with its subsidiaries, explores for, develops, produces, and markets crude oil, and natural gas and natural gas liquids.

EOG Resources’s sales growth this year is expected to be 47.7% and 9.3% for next year.

Year-on-year quarterly revenue growth grew by 271.3%, now sitting on 13.8B for the twelve trailing months.

Volume

Today’s last reported volume for EOG Resources is 3996670 which is 17.24% below its average volume of 4829630.

EOG Resources’s sales growth is a negative 0% for the current quarter and 58.9% for the next. The company’s growth estimates for the ongoing quarter and the next is 358.1% and 212.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.11%.

Volatility

EOG Resources’s last day, last week, and last month’s current volatility was 1.06%, 0.40%, and 2.62%, respectively.

EOG Resources’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.62% (day), 3.20% (last week), and 3.24% (last month), respectively.

EOG Resources’s Stock Yearly Top and Bottom Value

EOG Resources’s stock is valued at $89.31 at 20:22 EST, below its 52-week high of $93.07 and way above its 52-week low of $31.22.

EOG Resources’s Moving Average

EOG Resources’s value is way higher than its 50-day moving average of $77.68 and way above its 200-day moving average of $76.95.

3. Semler Scientific (SMLR)

36.2% sales growth and 76.81% return on equity

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States.

Semler Scientific’s sales growth this year is anticipated to be 52.8% and 23.6% for next year.

Year-on-year quarterly revenue growth grew by 124.6%, now sitting on 50.29M for the twelve trailing months.

Volume

Today’s last reported volume for Semler Scientific is 69336 which is 279.71% above its average volume of 18260.

Semler Scientific’s sales growth for the next quarter is 36.2%. The company’s growth estimates for the current quarter and the next is 4.9% and 7.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 76.81%.

Volatility

Semler Scientific’s last day, last week, and last month’s current volatility was 1.24%, 2.28%, and 2.13%, respectively.

Semler Scientific’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 13.04% (day), 7.05% (last week), and 5.19% (last month), respectively.

Semler Scientific’s Stock Yearly Top and Bottom Value

Semler Scientific’s stock is valued at $140.05 at 20:22 EST, below its 52-week high of $144.87 and way higher than its 52-week low of $53.51.

Semler Scientific’s Moving Average

Semler Scientific’s worth is way higher than its 50-day moving average of $118.83 and way higher than its 200-day moving average of $113.46.

4. Organogenesis Holdings (ORGO)

15.8% sales growth and 65.27% return on equity

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States.

Organogenesis Holdings ‘s sales growth this year is anticipated to be 36.7% and 10.7% for next year.

Year-on-year quarterly revenue growth grew by 78.6%, now sitting on 433.35M for the twelve trailing months.

Volume

Today’s last reported volume for Organogenesis Holdings is 33294 which is 96.89% below its average volume of 1070770.

Organogenesis Holdings ‘s sales growth for the next quarter is 15.8%. The company’s growth estimates for the current quarter and the next is a negative 68.4% and negative -40%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 65.27%.

Volatility

Organogenesis Holdings ‘s last day, last week, and last month’s current volatility was 1.83%, 6.74%, and 4.50%, respectively.

Organogenesis Holdings ‘s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.37% (day), 11.93% (last week), and 7.07% (last month), respectively.

Organogenesis Holdings ‘s Stock Yearly Top and Bottom Value

Organogenesis Holdings ‘s stock is valued at $10.80 at 20:22 EST, way under its 52-week high of $24.34 and way higher than its 52-week low of $3.44.

Organogenesis Holdings ‘s Moving Average

Organogenesis Holdings ‘s worth is way below its 50-day moving average of $14.67 and way below its 200-day moving average of $16.68.

5. Kinder Morgan (KMI)

6.8% sales growth and 5.5% return on equity

Kinder Morgan, Inc. operates as an energy infrastructure company in North America.

Kinder Morgan’s sales growth this year is expected to be 25.9% and a negative 12.1% for next year.

Year-on-year quarterly revenue growth grew by 23%, now sitting on 14.39B for the twelve trailing months.

Volume

Today’s last reported volume for Kinder Morgan is 15529800 which is 8.96% above its average volume of 14252300.

Kinder Morgan’s sales growth for the next quarter is 6.8%. The company’s growth estimates for the current quarter and the next is 14.3% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.5%.

Volatility

Kinder Morgan’s last day, last week, and last month’s current volatility was 0.44%, 1.11%, and 1.02%, respectively.

Kinder Morgan’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.20% (day), 1.96% (last week), and 2.03% (last month), respectively.

Kinder Morgan’s Stock Yearly Top and Bottom Value

Kinder Morgan’s stock is valued at $18.47 at 20:22 EST, under its 52-week high of $19.29 and way higher than its 52-week low of $11.45.

Kinder Morgan’s Moving Average

Kinder Morgan’s value is way higher than its 50-day moving average of $16.67 and above its 200-day moving average of $17.41.

LEAVE A REPLY

Please enter your comment!
Please enter your name here